| By Marketwire . | Article Rating: |
|
| November 20, 2008 05:17 PM EST | Reads: |
184 |
WINNIPEG, MANITOBA -- (Marketwire) -- 11/20/08 -- Starting in December of this year the federal Government will be handing out some serious money in the form of grants and bonds to people who set up a Registered Disability Savings Plan (RDSP). To get the RDSP you first must have the Disability Tax Credit in place either for yourself or a family member. Now is the time to explore eligibility for the Disability Tax Credit so that the RDSP can take care of the future.
Susana Scott, President, Brematson & Associates is pioneering a revolutionary approach in defining and interpreting disabilities as it relates to the disability tax credit. With respect, compassion and understanding Susana Scott represents the disabled, liaisons with the medical community, and educates the public to ensure that the disabled individual and their family receive the maximum benefit from the Disability Tax Credit.
Brematson & Associates Inc. 825 Sherbrook St. Wpg. MB
located in the Society for Manitobans with Disabilities Bldg
204-975-3276 (toll free) 866-763-6131
info.brematson@smd.mb.ca www.brematson.ca
Contacts:
Brematson & Associates Inc.
Advocate/Specialist Disability Issues
Susana Scott, President
(204) 975-3276 or Toll Free: 1-866-763-6131
(204) 975-3027 (FAX)
Email: info.brematson@smd.mb.ca
Website: www.brematson.ca
Published November 20, 2008 Reads 184
Copyright © 2008 Ulitzer, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
Related Stories
More Stories By Marketwire .
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
- 22nd Annual ROTH OC Growth Stock Conference Presenter Profiles
- ADDING and REPLACING 22nd Annual ROTH OC Growth Stock Conference Presenter Profiles
- Two-Year Results From CLARITY Study With Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
- Bazaarvoice Plans for Record-Breaking Year as It Brings Social Commerce to Brands Around the Globe
- Genzyme Corporation's Generous Benefaction to Enable the Creation of a Key Clinical Academic Post for Multiple Sclerosis, Neuroimmunological Diseases
- Project Lifesaver International Offers Added Security and Protection to Their Lifesaving Program with Xanboo
- Stem Cell Therapeutics Corp. Receives 'No Objection Letter' From Health Canada for the Phase IIa Clinical Trial in Traumatic Brain Injury Patients
- Natural Chelation Alternative Offers New, Non-Invasive Approach to Autism Spectrum Disorder Treatment
- Moonlight Madness Ski Event at Trollhaugen Benefits Courage Center
- Despite Recession, Integra Telecom Associates Gave Back More in 2009
- PatientsLikeMe Recognized in Fast Company's 2010 Ranking of World's 50 Most Innovative Companies
- Corey McPherson Nash Partners with Biogen Idec
- UK Stem Cell Foundation & MS Society Stem Cell Research Collaboration
- 22nd Annual ROTH OC Growth Stock Conference Presenter Profiles
- ADDING and REPLACING 22nd Annual ROTH OC Growth Stock Conference Presenter Profiles
- Defense Department to Support Fragile X Research
- Two-Year Results From CLARITY Study With Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
- Bazaarvoice Plans for Record-Breaking Year as It Brings Social Commerce to Brands Around the Globe
- Genzyme Corporation's Generous Benefaction to Enable the Creation of a Key Clinical Academic Post for Multiple Sclerosis, Neuroimmunological Diseases
- Project Lifesaver International Offers Added Security and Protection to Their Lifesaving Program with Xanboo
- Stem Cell Therapeutics Corp. Receives 'No Objection Letter' From Health Canada for the Phase IIa Clinical Trial in Traumatic Brain Injury Patients
- Natural Chelation Alternative Offers New, Non-Invasive Approach to Autism Spectrum Disorder Treatment
- Moonlight Madness Ski Event at Trollhaugen Benefits Courage Center
- Despite Recession, Integra Telecom Associates Gave Back More in 2009
- Contrary Opinion: CRM is a Hoax
- An Introduction to My Health 2.0 Blog
- Michael Jackson's Death from Cardiac Arrest
- Desiccated Thyroid as a Treatment Option
- RNL BIO Rescues a College Student from Autoimmune Hearing Loss
- About Disability Resource Exchange Social Network
- Blood Test May Predict Course of MS
- NMSDC Recognizes Top Regional Minority Suppliers
- National Institutes of Health Awards More Than $54 Million to Kaiser Permanente to Conduct Health Research
- Inclusion Has Come A Long Way..
- Chase and Facebook Announce 100 Small and Local Charities to Receive $25,000 Each from Chase Community Giving
- Merck Serono Receives Refuse to File Letter From FDA on Cladribine Tablets New Drug Application






























Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.